MGMT and glioblastoma: Rosas‐Alonso et al. detected of O6-methylguanine-DNA methyltransferase methylation in the plasma EV-DNA of glioblastoma patients with a remarkable sensitivity of 85.7%, and suggested EV-DNA-based liquid biopsy for monitoring disease progression in IDH-wild type glioblastoma patients [139].